Life Sciences Investing

Argosy Healthcare Partners (AHP) has announced the recapitalization of Connect Life Sciences (CLS).

CLS, founded in 2020 and based in Orlando, Florida, provides recruitment services to pharmaceutical, biotechnology and medical device companies.

AHP, based in Wayne, Pa., is

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Argosy Invests in Connect Life Sciences

Altaris has announced it will acquire Sharecare (NASDAQ: SHCR) for $1.43 in cash per share, or about $518 million.

Sharecare, founded in 2010 and based in Atlanta, is a digital health company that provides technology and services across the

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Altaris to Acquire Sharecare for $518 Million

Vista Equity Partners will acquire Model N (NYSE: MODN) for approximately $1.25 billion, according to a news release.

Model N, founded in 1999 and based in San Mateo, Calif., is a provider of revenue optimization and compliance software

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Vista to Acquire Model N for $1.25 Billion

New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 billion, according to industry reports.

ILC, founded in 1947 and based in Frederica, Del., designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: New Mountain to Sell ILC Dover for $2.3 Billion

Arsenal Capital Partners will acquire Fortrea’s enabling services segment and patient access businesses, according to a news release.

Fortea (Nasdaq: FTRE), a global clinical research organization based in Research Triangle Park, N.C., is divesting its Endpoint Clinical and Fortrea

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Arsenal Acquires Multiple Companies From Fortrea

Linden Capital Partners has announced the acquisition of Alcresta Therapeutics.

Alcresta, founded in 2011 and based in Newton, Mass., develops and commercializes enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.

Linden

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Linden Acquires Alcresta Therapeutics

Vesey Street Capital Partners (VSCP) has announced the completion of a majority recapitalization of Inceptua Group.

Inceptua, founded in 1997 and with its U.S. office in Princeton, N.J., is provider of clinical trial supplies and related services.

VSCP

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Vesey Recaps Inceptua Group